A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : MMPs / matrix-degrading metalloproteinases

[Related PubMed/MEDLINE]
Total Number of Papers: 39
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   MMPs  (>> Co-occurring Abbreviation)
Long Form:   matrix-degrading metalloproteinases
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2021 Macrophage depletion induces edema through release of matrix-degrading proteases and proteoglycan deposition. CSF1R, HA, TAM
2017 Evidence for the Involvement of Matrix-Degrading Metalloproteinases (MMPs) in Atherosclerosis. ---
2013 Antisense MMP-9 RNA inhibits malignant glioma cell growth in vitro and in vivo. pcDNA-ASMMP9
2013 Characterization of joint disease in mucopolysaccharidosis type I mice. GAGs, MPS
2010 Inhibiting extracellular matrix metalloproteinase inducer maybe beneficial for diminishing the atherosclerotic plaque instability. EMMPRIN
2009 MMP-9 gene silencing by a quantum dot-siRNA nanoplex delivery to maintain the integrity of the blood brain barrier. BBB, BMVEC, CNS, ECM, QD, TIMP-1
2007 High plasma levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) and interleukin-8 (IL-8) characterize patients prone to ventricular fibrillation complicating myocardial infarction. IL-8, MI, TIMP-1, VF
2006 Matrix metalloproteinases: a potential therapeutic target in atherosclerosis. SMC
2006 Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice. CTLs, HBV, HMGB1, PMNs
10  2005 Joint and bone disease in mucopolysaccharidoses VI and VII: identification of new therapeutic targets and biomarkers using animal models. MPS
11  2005 Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates. VSMC
12  2004 Mitochondrial redox control of matrix metalloproteinases. ROS
13  2004 MMPs, cadherins, and cell proliferation. ---
14  2004 Tumor necrosis factor alpha induces human atrial myofibroblast proliferation, invasion and MMP-9 secretion: inhibition by simvastatin. TNF-alpha
15  2002 Matrix metalloproteinases and tissue inhibitors of metalloproteinases in hamster aortic atherosclerosis: correlation with in-situ zymography. ECM
16  2002 Regulation of metalloproteinases by nitric oxide in human trophoblast cells in culture. NO
17  2002 Steroids and cytokines in endometrial angiogenesis. EPO, FGFs, TSP-1, VEGF
18  2001 Injury induces dedifferentiation of smooth muscle cells and increased matrix-degrading metalloproteinase activity in human saphenous vein. TIMP, VSMC
19  2001 Lacidipine [correction of Lalsoacidipine] modulates the secretion of matrix metalloproteinase-9 by human macrophages. TIMP-1
20  2000 A deficit in collagenase activity contributes to impaired migration of aged microvascular endothelial cells. TIMP1
21  2000 Phorbol 12-myristate 13-acetate induces alteration in mucin gene expression and biological properties of colon cancer cells. PKC, PMA
22  2000 Therapeutic potential of matrix metalloproteinase inhibitors in atherosclerosis. ---
23  1999 Increased secretion of basement membrane-degrading metalloproteinases in pig saphenous vein into carotid artery interposition grafts. SMCs
24  1999 Interleukin-8 mediates downregulation of tissue inhibitor of metalloproteinase-1 expression in cholesterol-loaded human macrophages: relevance to stability of atherosclerotic plaque. IL, oxLDL, TIMPs
25  1998 Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques. ---
26  1998 Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. HSP60, LPS, TNF-alpha
27  1997 Surgical preparative injury and neointima formation increase MMP-9 expression and MMP-2 activation in human saphenous vein. SMC
28  1996 Evolution of disintegrin cysteine-rich and mammalian matrix-degrading metalloproteinases: gene duplication and divergence of a common ancestor rather than convergent evolution. MDC
29  1996 Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury. SMC
30  1996 Proteolytic cascade enzymes increase in focal cerebral ischemia in rat. MCAO, PA, SHR, WKY
31  1996 TNF-alpha-mediated expression of membrane-type matrix metalloproteinase in rheumatoid synovial fibroblasts. MT-MMP, RA, TNF
32  1995 Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. ---
33  1995 Overexpression of matrix metalloproteinase-7 mRNA in human colon carcinomas. MMP-7
34  1995 Synthesis and secretion of matrix-degrading metalloproteases by human skeletal muscle satellite cells. ---
35  1994 Matrix-degrading metalloproteinases in tumor progression. ---
36  1993 Expression pattern of metalloproteinases and their inhibitors changes with the progression of human sporadic colorectal neoplasia. high
37  1993 Tetracycline and doxycycline inhibit pleural fluid metalloproteinases. A possible mechanism for chemical pleurodesis. ---
38  1991 EGF and TGF alpha influence in vitro lung development by the induction of matrix-degrading metalloproteinases. ---
39  1991 Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas. ---